Publication: Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
Issued Date
2021-03-01
Resource Type
ISSN
17517176
15246175
15246175
Other identifier(s)
2-s2.0-85103146577
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Hypertension. Vol.23, No.3 (2021), 411-421
Suggested Citation
Kazuomi Kario, Satoshi Hoshide, Yook Chin Chia, Peera Buranakitjaroen, Saulat Siddique, Jinho Shin, Yuda Turana, Sungha Park, Kelvin Tsoi, Chen Huan Chen, Hao Min Cheng, Takeshi Fujiwara, Yan Li, Van Minh Huynh, Michiaki Nagai, Jennifer Nailes, Jorge Sison, Arieska Ann Soenarta, Guru Prasad Sogunuru, Apichard Sukonthasarn, Jam Chin Tay, Boon Wee Teo, Narsingh Verma, Tzung Dau Wang, Yuqing Zhang, Ji Guang Wang Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network. Journal of Clinical Hypertension. Vol.23, No.3 (2021), 411-421. doi:10.1111/jch.14128 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78371
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
Author(s)
Kazuomi Kario
Satoshi Hoshide
Yook Chin Chia
Peera Buranakitjaroen
Saulat Siddique
Jinho Shin
Yuda Turana
Sungha Park
Kelvin Tsoi
Chen Huan Chen
Hao Min Cheng
Takeshi Fujiwara
Yan Li
Van Minh Huynh
Michiaki Nagai
Jennifer Nailes
Jorge Sison
Arieska Ann Soenarta
Guru Prasad Sogunuru
Apichard Sukonthasarn
Jam Chin Tay
Boon Wee Teo
Narsingh Verma
Tzung Dau Wang
Yuqing Zhang
Ji Guang Wang
Satoshi Hoshide
Yook Chin Chia
Peera Buranakitjaroen
Saulat Siddique
Jinho Shin
Yuda Turana
Sungha Park
Kelvin Tsoi
Chen Huan Chen
Hao Min Cheng
Takeshi Fujiwara
Yan Li
Van Minh Huynh
Michiaki Nagai
Jennifer Nailes
Jorge Sison
Arieska Ann Soenarta
Guru Prasad Sogunuru
Apichard Sukonthasarn
Jam Chin Tay
Boon Wee Teo
Narsingh Verma
Tzung Dau Wang
Yuqing Zhang
Ji Guang Wang
Other Contributor(s)
Hiroshima City Asa Citizens Hospital
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
NUS Yong Loo Lin School of Medicine
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Chiang Mai University
Medical Center Manila
Punjab Medical Center
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
NUS Yong Loo Lin School of Medicine
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Chiang Mai University
Medical Center Manila
Punjab Medical Center
Abstract
Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia.